Cargando…

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective

Vaccines are key in charting a path out of the COVID-19 pandemic. However, development of new vaccines is highly dependent on availability of analytical methods for their design and evaluation. This paper highlights the challenges presented in having to rapidly develop vaccine analytical tools durin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldwin, Jeremy, Piplani, Sakshi, Sakala, Isaac G, Honda-Okubo, Yoshikazu, Li, Lei, Petrovsky, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2021
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516068/ https://www.ncbi.nlm.nih.gov/pubmed/34645288 http://dx.doi.org/10.4155/bio-2021-0096

Ejemplares similares

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Komiya, Tomoyoshi, et al.
Publicado: (2021)

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
por: Li, Lei, et al.
Publicado: (2022)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M(pro)) as Potential COVID-19 Therapies
por: Piplani, Sakshi, et al.
Publicado: (2022)

Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase
por: Piplani, Sakshi, et al.
Publicado: (2022)

Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics
por: Piplani, Sakshi, et al.
Publicado: (2023)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
por: Piplani, Sakshi, et al.
Publicado: (2021)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2023)

Rapid tranquillisation: a global perspective
por: Nadkarni, Pallavi, et al.
Publicado: (2015)

Vaccines today, vaccines tomorrow: a perspective
por: Loucq, Christian
Publicado: (2013)

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

An overview of city analytics
por: Higham, Desmond J., et al.
Publicado: (2017)

Perspectives on the Direction of Cancer Prehabilitation in the Pandemic and Beyond
por: Tay, San San
Publicado: (2022)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

Deployment of an Interdisciplinary Predictive Analytics Task Force to Inform Hospital Operational Decision-Making During the COVID-19 Pandemic
por: Pollock, Benjamin D., et al.
Publicado: (2021)

Primary Care Evolution: Clinic Staff and Patient Perspectives of the Rapid Upscale of Virtual Primary Care during the COVID‐19 Pandemic
por: Kelley, Lynette, et al.
Publicado: (2021)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

Molecular Dynamics of Rab7::REP1::GGTase-II Ternary Complex and Identification of Their Putative Drug Binding Sites
por: Sindhu, Meenakshi, et al.
Publicado: (2013)

Large Falciform Ligament Cyst in a Child: A Rare Entity of Peritoneal Cysts and Review of the Literature
por: Yhoshu, Enono, et al.
Publicado: (2020)

A perspective on new dilemmas in scientific publishing in the time of a pandemic
por: Arjuman, Albina
Publicado: (2023)

Standardizing Analytic Methods and Reporting in Activity Monitor Validation Studies
por: WELK, GREGORY J., et al.
Publicado: (2019)

In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies
por: Rajapaksha, Harinda, et al.
Publicado: (2014)

Analytical continuation of two-dimensional wave fields
por: Assier, Raphaël C., et al.
Publicado: (2021)

Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015)

Increased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics
por: Kiyonami, Reiko, et al.
Publicado: (2011)

The Present Methods of the King Institute in the Production of Vaccine Lymph
por: King, H. H., et al.
Publicado: (1933)

Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations
por: Gronholm, P. C., et al.
Publicado: (2021)

Overcoming the effect of pandemic fatigue on vaccine hesitancy—Will belief in science triumph?
por: Bodas, Moran, et al.
Publicado: (2022)

Rapid development of a ventilator for use during the COVID-19 pandemic: Clinical, human factor & engineering considerations
por: Wittenberg, M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q6no7qhp4fc7tg6kraiv07lrgh